Cargando…
Deoxypyrimidine monophosphate bypass therapy for thymidine kinase 2 deficiency
Autosomal recessive mutations in the thymidine kinase 2 gene (TK2) cause mitochondrial DNA depletion, multiple deletions, or both due to loss of TK2 enzyme activity and ensuing unbalanced deoxynucleotide triphosphate (dNTP) pools. To bypass Tk2 deficiency, we administered deoxycytidine and deoxythym...
Autores principales: | Garone, Caterina, Garcia-Diaz, Beatriz, Emmanuele, Valentina, Lopez, Luis C, Tadesse, Saba, Akman, Hasan O, Tanji, Kurenai, Quinzii, Catarina M, Hirano, Michio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154130/ https://www.ncbi.nlm.nih.gov/pubmed/24968719 http://dx.doi.org/10.15252/emmm.201404092 |
Ejemplares similares
-
Bioavailability and cytosolic kinases modulate response to deoxynucleoside therapy in TK2 deficiency
por: Lopez-Gomez, Carlos, et al.
Publicado: (2019) -
Effects of Inhibiting CoQ(10) Biosynthesis with 4-nitrobenzoate in Human Fibroblasts
por: Quinzii, Catarina M., et al.
Publicado: (2012) -
Pyrimidine Salvage Enzymes Are Essential for De Novo Biosynthesis of Deoxypyrimidine Nucleotides in Trypanosoma brucei
por: Leija, Christopher, et al.
Publicado: (2016) -
Supramolecular Assembly of
Uridine Monophosphate (UMP) and Thymidine
Monophosphate (TMP) with a Dinuclear Copper(II) Receptor
por: Rhaman, Md Mhahabubur, et al.
Publicado: (2017) -
Advances in Thymidine Kinase 2 Deficiency: Clinical Aspects, Translational Progress, and Emerging Therapies
por: Berardo, Andres, et al.
Publicado: (2022)